A Dark Vector Cognition product

Item 6. EXHIBITS

9K characters. Original on sec.gov ·

Item 6. EXHIBITS

The 3 tables in Item 6. EXHIBITS as one CSV, figures in aligned columns. For subscribers: paste your API key. One API call. Plans from $19 a month, see pricing.

Incorporated by Reference
Exhibit NumberExhibit DescriptionFormFile No.Date of First FilingExhibit NumberProvided Herewith
10.1*Offer Letter, dated September 11, 2026, between DexCom, Inc. and Jereme Sylvain.————X
31.1Certification of Chief Executive Officer Pursuant to Securities Exchange Act Rule 13a-14(a).————X
31.2Certification of Chief Financial Officer Pursuant to Securities Exchange Act Rule 13a-14(a).————X
32.1**Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350 and Securities Exchange Act Rule 13a-14(b).————X
32.2**Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350 and Securities Exchange Act Rule 13a-14(b).————X
101.INSInline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL documentX
101.SCHInline XBRL Taxonomy Extension Schema DocumentX
101.CALInline XBRL Taxonomy Extension Calculation Linkbase DocumentX
101.DEFInline XBRL Taxonomy Extension Definition Linkbase DocumentX
101.LABInline XBRL Taxonomy Extension Label Linkbase DocumentX
101.PREInline XBRL Taxonomy Extension Presentation Linkbase DocumentX
104Cover Page Interactive Data File - the cover page from the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026 is formatted in Inline XBRLX
*Represents a management contract or compensatory plan, contract or arrangement.
**This certification is not deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that Dexcom specifically incorporates it by reference.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

DEXCOM, INC. (Registrant)
Dated:October 29, 2026By:/s/ JACOB LEACH
Jacob Leach, President and Chief Executive Officer (Principal Executive Officer)
Dated:October 29, 2026By:/s/ JEREME SYLVAIN
Jereme Sylvain, Executive Vice President, Chief Operating Officer and Chief Financial Officer (Principal Financial and Accounting Officer)

Previous: Item 5. OTHER INFORMATION